Boc-L-Arg(Tos)-OH is a protected amino acid derivative of L-arginine in which the α-amino group is masked by a Boc (tert-butoxycarbonyl) protecting group and the side-chain guanidinium functionality is substituted with a tosyl (Tos) group. The molecule contains both a free carboxylic acid and a Boc-protected amino group, while the guanidinium side chain bears the Tos protection that modulates its hydrogen-bonding and basicity during handling and coupling. In peptide synthesis workflows, this orthogonally protected arginine analogue functions as a protected building block that supports stepwise assembly by controlling chemoselectivity at the amino and guanidinium functionalities.
CAT No: CP25336
CAS No:13836-37-8
Synonyms/Alias:Boc-Arg(Tos)-OH;13836-37-8;Boc-Arg(Tos);Nalpha-Boc-Nomega-tosyl-L-arginine;n2-(tert-butoxycarbonyl)-n5-{n-[(4-methylphenyl)sulfonyl]carbamimidoyl}-l-ornithine;N(alpha)-boc-N(omega)-tosyl-L-arginine;C18H28N4O6S;AmbotzBAA1068;PubChem12923;N(2)-tert-Butoxycarbonyl-N(G)-tosyl-L-arginine;AC1Q6U2W;15506_ALDRICH;BOC-Nomega-tosyl-L-arginine;AC1L364O;SCHEMBL8697164;15506_FLUKA;MolPort-003-926-823;WBIIPXYJAMICNU-AWEZNQCLSA-N;ACT07198;L-Ornithine,N2-((1,1-dimethylethoxy)carbonyl)-N5-(imino(((4-methylphenyl)sulfonyl)amino)methyl)-;ZINC4534345;EINECS237-549-2;AR-1K5512;AKOS015924225;AKOS015963128
Chemical Name:N-alpha-t-Butyloxycarbonyl-N-gamma-4-toluolsulfonyl-L-arginine
Boc-L-Arg(Tos)-OH is a Boc-protected L-arginine building block bearing a tosyl (Tos) protected guanidinium side chain, providing orthogonal control of the backbone and side-chain reactivity during peptide assembly. This protected amino acid is commonly used in peptide synthesis workflows where the guanidinium group must be masked to prevent undesired side reactions, while the Boc group enables controlled N-terminal deprotection. The combination of Boc on the alpha-amino function and Tos on the arginine side chain makes it a practical choice for constructing peptides with arginine residues in complex sequences.
1. Solid-Phase Peptide Synthesis
Boc-L-Arg(Tos)-OH is frequently selected for solid-phase peptide synthesis to incorporate arginine residues with minimized guanidinium side-chain reactivity during chain elongation. Peptide synthesis groups use this building block to maintain sequence fidelity in longer or difficult sequences where unprotected arginine side chains can lead to aggregation, side reactions, or incomplete coupling. The Boc-protected alpha-amino functionality supports standard stepwise N-terminal activation and deprotection cycles, while the Tos group helps keep the guanidinium protected until the intended final deprotection stage. This makes the reagent a common component in workflows for preparing arginine-containing peptides for biochemical assays, protein interaction studies, and reference materials.
2. Arginine-Containing Peptide Libraries
Boc-L-Arg(Tos)-OH is also used in peptide library construction where controlled arginine incorporation is required across multiple sequences or variants. Researchers building focused libraries for structure-activity relationship studies, epitope mapping, or binding-site exploration often prefer side-chain-protected arginine blocks to ensure that each coupling step proceeds without premature guanidinium participation. The Boc/Tos protection pattern supports reproducible assembly and downstream conversion to the native arginine side chain after global deprotection and purification. As a result, this reagent is routinely employed in parallel synthesis formats used by peptide chemistry teams developing modified peptides, constrained analogs, or sequence variants that require consistent arginine presentation.
3. Pharmaceutical Intermediate Peptide Segments
Boc-L-Arg(Tos)-OH finds practical use in the preparation of arginine-containing peptide segments used as intermediates in pharmaceutical and medicinal chemistry development. Custom peptide manufacturing and process development teams often rely on side-chain-protected amino acid building blocks to control reactivity during segment coupling, fragment assembly, and late-stage modifications. The Tos-protected guanidinium helps reduce side reactions during intermediate formation, enabling reliable generation of protected peptide fragments that can be carried forward into further synthetic steps. This application is particularly relevant when the arginine residue must be introduced early in a synthetic sequence but only unmasked at a later stage to match the required final peptide or conjugate format.
4. Analytical Reference Peptide Synthesis
Boc-L-Arg(Tos)-OH is used to synthesize arginine-containing peptides employed as analytical references in method development and characterization workflows. Analytical chemistry teams preparing calibration standards, retention-time references, or LC-MS/MS benchmarking peptides benefit from the predictable incorporation of arginine under controlled protection conditions, which improves batch-to-batch consistency for reference materials. The protected building block supports reliable peptide assembly, while the final deprotection step yields the native arginine side chain required for accurate comparison against target peptides or assay components. This makes Boc-L-Arg(Tos)-OH a practical reagent for generating well-defined peptide standards used in peptide quantification, impurity profiling, and structural confirmation studies.
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.